Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/13/2003US20030211519 Identifying angiogenesis inhibitor for treating cell proliferative disorders; antitumor agents
11/13/2003US20030211515 Comprises nucleotide sequences coding matrix protein for diagnosing and treating cancer
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211511 Nucleic acids and proteins with thioredoxin reductase activity
11/13/2003US20030211496 Kit for calibrating solid supports/matrices associated with polynucleotide hybridization methodologies; genetic analysis
11/13/2003US20030211494 Recovering nucleotide sequences coding amylases, aminocyclases and/or amidohydrolases; diagnostic tools
11/13/2003US20030211493 Comprises membrane protein for diagnosis, prevention and treatment of infections, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
11/13/2003US20030211490 Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
11/13/2003US20030211488 Nanoparticle probs with Raman spectrocopic fingerprints for analyte detection
11/13/2003US20030211486 Compositions and methods for detecting polymorphisms associated with pigmentation
11/13/2003US20030211483 Methods for the enrichment of low-abundance polynucleotides
11/13/2003US20030211481 Method for identifying cellular targets
11/13/2003US20030211476 Modulating protein expression/translation/concentration in cells; vaccine/drug delivery
11/13/2003US20030211467 Using monoclonal antibody for diagnosis, prevention and treatment of viral infections; immunotherapy; genetic vaccine
11/13/2003US20030211462 Directionally cloned random cDNA expression vector libraries, compositions and methods of use
11/13/2003US20030211457 Methods and kits for testing mutagenicity
11/13/2003US20030211455 Methods and compositions for identifying ligands for nuclear receptors
11/13/2003US20030211117 Synthetic antigen for the detection of aids-related disease
11/13/2003US20030211112 EGFR ligands and methods of use
11/13/2003US20030211106 Binding tumor necrosis factor to antibody
11/13/2003US20030211101 Vascular endothelial growth factor-like protein from ORF viruses binds and activates mammalian VEGF receptor-2, and uses thereof
11/13/2003US20030211100 Gene therapy; nucleic acid coding immunoglobulins; anticancer agents
11/13/2003US20030211099 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2
11/13/2003US20030211097 Epidermal growth factor; antitumor, anticancer agents
11/13/2003US20030211096 Detection of genes which amplification genome cells; anticancer, antitumor agent
11/13/2003US20030211089 Transgenic algae for delivering antigens to an animal
11/13/2003US20030211087 Separation of mixture; insertion a nucleic acid which codes fluorescent protein; gene expression; neuron progenitor cell
11/13/2003US20030211086 Minicell-based selective absorption
11/13/2003US20030211080 Congestive heart failure; monitoring gene expression; supplying adeno-associated viral vector
11/13/2003US20030211040 Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain
11/13/2003US20030211013 Apparatus for detection and analysis of DNA on microarrays
11/13/2003CA2763666A1 Keratinocytes expressing exogenous angiogenic growth factors
11/13/2003CA2524569A1 A method of regulating gene expression
11/13/2003CA2495787A1 Methods for delivering nucleic acid molecules into cells and assessment thereof
11/13/2003CA2491708A1 Non-viral gene delivery system
11/13/2003CA2487274A1 Spermine chemically linked to lipids and cell-specific targeting molecules as a transfection agent
11/13/2003CA2485216A1 Therapeutic use of pacap, maxadilan, pacap receptor agonist and/or adcyap1r1 in the treatment of cns disorders
11/13/2003CA2485110A1 Expression system for large functional proteins
11/13/2003CA2485089A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/13/2003CA2485060A1 Method for producing multiple unsaturated fatty acids in plants
11/13/2003CA2485038A1 Transgenic animal model for spliceosome-mediated rna trans-splicing
11/13/2003CA2484940A1 Methods and compositions for the modification of nucleic acids
11/13/2003CA2484930A1 Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries
11/13/2003CA2484920A1 Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression
11/13/2003CA2484676A1 Kinase anchor protein muteins, peptides thereof, and related methods
11/13/2003CA2484538A1 Vectors with modified protease-dependent tropism
11/13/2003CA2484425A1 Fusions of cytokines and tumor targeting proteins
11/13/2003CA2484420A1 Antibodies specific for human cd22 and their therapeutic and diagnostic uses
11/13/2003CA2484360A1 In vitro mutagenesis, phenotyping, and gene mapping
11/13/2003CA2484287A1 Pharmaceutical- or gene-carrier compositions with reduced hemagglutinating activity
11/13/2003CA2484244A1 Stable cytochrome p450 24 (cyp24) expressing cell line and methods and uses thereof
11/13/2003CA2484185A1 Site specific listeria integration vectors and methods for using the same
11/13/2003CA2484182A1 Novel antibody binding tcr and tirc7 and its use in therapy and diagnosis
11/13/2003CA2484155A1 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein
11/13/2003CA2484153A1 Methods for discovering tumor biomarkers and diagnosing tumors
11/13/2003CA2483996A1 Promoters exhibiting endothelial cell specificity and methods of using same
11/13/2003CA2483915A1 Vectors having both isoforms of b-hexosaminidase
11/13/2003CA2483912A1 Alcam and alcam modulators
11/13/2003CA2483909A1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003CA2483891A1 Gene targeting using replicating dna molecules
11/13/2003CA2483851A1 Methods and compositions for use in homologous recombination
11/13/2003CA2483782A1 Temporal seed promoters for expressing genes in plants
11/13/2003CA2483653A1 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
11/13/2003CA2483544A1 Seed specific usp promoters for expressing genes in plants
11/13/2003CA2483478A1 Factor vii or viia polypeptide variants
11/13/2003CA2483050A1 Optimization of transgene expression in mammalian cells
11/13/2003CA2483047A1 Ice1, a regulator of cold induced transcriptome and freezing tolerance in plants
11/13/2003CA2483038A1 Immunoglobulin-domain containing cell surface recognition molecules
11/13/2003CA2482879A1 Transgenic high tryptophan plants
11/13/2003CA2482812A1 Mitochondrial polymorphisms linked to a predisposition for the development of inappropriate scarring or fibrosis
11/13/2003CA2462879A1 Immunoconjugates for the treatment of tumours
11/13/2003CA2454837A1 Novel 88 phage vectors
11/13/2003CA2427386A1 Genotyping by amplicon melting curve analysis
11/12/2003EP1361433A2 Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
11/12/2003EP1361284A1 Process for generating sequence-specific proteases by directed evolution and use thereof
11/12/2003EP1361278A2 Process for the production of amino acids using phosphoglucose isomerases from coryneform bacteria
11/12/2003EP1361277A1 Optimization of transgene expression in mammalian cells
11/12/2003EP1361276A1 Pro-urokinase mutants
11/12/2003EP1361275A1 Cloned DNA polymerases from thermotoga neapolitana and mutants thereof
11/12/2003EP1361274A1 Polypeptide having alpha-isomaltosylglucosaccharide synthase activity
11/12/2003EP1361273A2 Interleukin-3 (IL-3) multiple mutation polypeptides
11/12/2003EP1361272A1 Neuritin, a neurogene
11/12/2003EP1361271A2 Isolated nonapeptide derived from MAGE-3 gene and presented by HLA-A1, and uses thereof
11/12/2003EP1361270A2 Disruption of the REDK gene
11/12/2003EP1361269A1 Delivery of gene products via mesangial cells expressing an exogenous gene
11/12/2003EP1361266A1 Transplantation cell kits for re-myelination in nerve cells
11/12/2003EP1361229A2 Use of Tyrosine Kinase (PYK2) to produce antibodies
11/12/2003EP1360965A1 Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases
11/12/2003EP1360962A2 Interferon tau composition and methods of use
11/12/2003EP1360898A1 Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus
11/12/2003EP1360560A2 Receptor selectivity mapping
11/12/2003EP1360504A2 Method for screening compounds for activity in treating an osteoclast related bone disease
11/12/2003EP1360501A2 Method of identifying conformation-sensitive binding peptides and uses thereof
11/12/2003EP1360500A2 Methods for selective targeting
11/12/2003EP1360498A2 Latent human tuberculosis model, diagnostic antigens, and methods of use
11/12/2003EP1360496A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells
11/12/2003EP1360490A1 Nucleic-acid programmable protein arrays
11/12/2003EP1360489A1 Low affinity screening method
11/12/2003EP1360335A2 Methods for identifying the target of a compound which inhibits cellular proliferation
11/12/2003EP1360334A1 Methods of using mammalian rnase h and compositions thereof
1 ... 2377 2378 2379 2380 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2394 2395 2396 2397 ... 4023